# Fetuin-A as a predicator of sarcopenic left ventricular dysfunction

**Authors:** Wei-Ting Chang, Wei-Chuan Tsai, Chih-Hsing Wu, Yen-Wei Lee, Yun-Lin Tai, Yi-Heng Li, Liang-Miin Tsai, Jyh-Hong Chen, Ping-Yen Liu

PMC · DOI: 10.1038/srep12078 · Scientific Reports · 2015-07-10

## TL;DR

This study shows that Fetuin-A levels are higher in elderly people with sarcopenia and are linked to heart function decline.

## Contribution

The study identifies Fetuin-A as a potential biomarker for sarcopenic left ventricular dysfunction in the elderly.

## Key findings

- Fetuin-A levels were significantly higher in sarcopenic elderly patients compared to non-sarcopenic individuals.
- Higher Fetuin-A levels were associated with impaired diastolic and systolic heart functions in sarcopenic patients.
- Older age and impaired diastolic function were also significantly linked to sarcopenic left ventricular dysfunction.

## Abstract

Sarcopenia is an aging condition involving low muscle mass and function. Fetuin-A (FetA) appears to be a factor for body composition remodeling. We hypothesized that age increases FetA levels and deteriorates the myocardial function by affecting diastolic function, especially in people with sarcopenia. We enrolled 541 asymptomatic elderly (≥65 years) patients. Compared with non-sarcopenic population, FetA levels were significantly elevated in the ninety-two (17%) patients (79 ± 6 years; male: 34.7%) diagnosed with sarcopenia (621.1 ± 140.7 vs. 697.3 ± 179.6 μg/ml, < 0.001). Sarcopenic left ventricular dysfunction (S-LVD) was defined by the coexistence of sarcopenia and systolic impairment (LVEF < 50%) and 23 (4.3%) of them met the criteria. Patients with S-LVD showed relatively reduced systolic heart function, higher end-diastolic pressure and a higher FetA level (all p < 0.001) than did those with sarcopenia but without LV dysfunction (S-NLVD). Conversely, in the group without sarcopenia, FetA levels were similar regardless of systolic function. Multivariable logistic regression showed that older age, impaired diastolic function, and higher FetA levels were significantly associated with S-LVD. In conclusion, we found that FetA was significantly higher in elderly patients with sarcopenia, which was associated with impaired diastolic and systolic functions.

## Linked entities

- **Proteins:** AHSG (alpha 2-HS glycoprotein)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, AHSG (alpha 2-HS glycoprotein) [NCBI Gene 197] {aka A2HS, AHS, APMR1, FETUA, HSGA}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, Atp8b5 (ATPase, class I, type 8B, member 5) [NCBI Gene 320571] {aka 4930417M19Rik, Feta}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** stroke (MESH:D020521), cardiac dysfunction (MESH:D006331), LV systolic and diastolic dysfunction (MESH:D018487), cardiovascular disease (MESH:D002318), deaths (MESH:D003643), HTN (MESH:D006973), myocardial infarction (MESH:D009203), of the myocardium (MESH:D017682), chronic kidney disease (MESH:D051436), wasting of skeletal muscle (MESH:D005207), CAD (MESH:D003324), muscle loss (MESH:D009135), metabolic syndrome (MESH:D024821), ischemic stroke (MESH:D002544), Ischemic cardiomyopathy (MESH:D009202), cancer (MESH:D009369), coronary and valvular calcification (MESH:D003323), cardiac remodeling (MESH:D020257), Diabetes (MESH:D003920), rigidity (MESH:D009127), LVEF (MESH:D054144), insulin resistance (MESH:D007333), Arrhythmia (MESH:D001145), loss of muscle mass (MESH:C536030), chronic inflammation (MESH:D007249), calcification (MESH:D002114), dyslipidemia (MESH:D050171), CKD (MESH:D012080), systolic as (MESH:D000092244), acute ischemic stroke (MESH:D000083242), Sarcopenic Heart Failure (MESH:D006333), hypertrophy (MESH:D006984), Sarcopenia (MESH:D055948), myocardial stiffness (MESH:C566112)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4498243/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4498243/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC4498243/full.md

---
Source: https://tomesphere.com/paper/PMC4498243